Dr. Gerald Diaz @GeraldMD
24.0M 13.9K 7.3K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
16 results
management hivaids infections idsa comparison mycobacterium 2016 aace aafp aviumcomplex bisphosphonates candida candidiasis capsulatum chagas cmv cytomegalovirus diabetes disease dosing
Pharmacologic Treatment of Hyperthyroidism #Hyperthyroidism #Treatment #Management #Pharmacology #Medications #Comparison #Table #Endocrinology #AAFP #Propylthiouracil #Methimazole
Pharmacologic Treatment ... Hyperthyroidism #Treatment ... #Management #Pharmacology ... #Medications #Comparison ... #Table #Endocrinology
►
 Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity Mechanism of Action,
Table of Weight-Loss ... Medications approved ... the long-term treatment ... Mechanism of Action, Dose ... WeightLoss #AACE #2016 #Pharmacology
Bisphosphonates for Osteoporosis Treatment or Prevention Bisphosphonates are common medications used in the treatment and prevention
or Prevention ... Bisphosphonates are common medications ... and prevention ... Schedule #Frequency #Pharmacology ... #Endocrinology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
be considered (doses ... Disease Note: Treatment ... PO in 2 divided doses ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
Recommendations for Preventing ... Encephalitis in HIV-AIDS Indications ... Encephalitis #IDSA #Prevention ... #Treatment #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... mucosal #IDSA #Prevention ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
Achieve a total dose ... Leishmaniasis #Prevention ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
Infections in HIV-AIDS Preventing ... ., concomitant medications ... injection) for 1–4 doses ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS Pre-Exposure Prevention of VZV
Recommendations for Preventing ... Primary Infection Indications ... (Varivax™), 2 doses ... #opportunistic ... infections #HIVAIDS #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... drug to remain stable ... take any other medications ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
empty